These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1977807)

  • 1. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
    Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
    J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.
    Meliconi R; Senaldi G; Sturani C; Galavotti V; Facchini A; Gasbarrini G; Vergani D
    Clin Immunol Immunopathol; 1990 Oct; 57(1):64-73. PubMed ID: 2394036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
    Senaldi G; Makinde VA; Vergani D; Isenberg DA
    Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
    Senaldi G; Lupoli S; Vergani D; Black CM
    Arthritis Rheum; 1989 Oct; 32(10):1262-7. PubMed ID: 2803327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation before, during and after cardiopulmonary bypass.
    Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
    Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation by cellulosic dialysis membranes.
    Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
    J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical and alternative complement pathway activation in paracoccidioidomycosis.
    de Messias IT; Mohren D
    J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation and immune complexes in early congenital HIV infection.
    Jarvis JN; Taylor H; Iobidze M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):480-5. PubMed ID: 7697445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
    Freysdottir J; Sigfusson A
    J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J; An L; Zhang Z
    Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in neonatal infection.
    Peakman M; Senaldi G; Liossis G; Gamsu HR; Vergani D
    Arch Dis Child; 1992 Jul; 67(7 Spec No):802-7. PubMed ID: 1519979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
    Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
    J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome.
    Kuypers DR; Lerut E; Evenepoel P; Maes B; Vanrenterghem Y; Van Damme B
    Transplantation; 2003 Jul; 76(1):102-8. PubMed ID: 12865794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.
    Hopkinson ND; Powell RJ
    J Clin Pathol; 1992 Jan; 45(1):66-7. PubMed ID: 1740520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the complement system in primary sclerosing cholangitis.
    Senaldi G; Donaldson PT; Magrin S; Farrant JM; Alexander GJ; Vergani D; Williams R
    Gastroenterology; 1989 Dec; 97(6):1430-4. PubMed ID: 2583409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
    Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
    Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.